Literature DB >> 34218459

The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes.

Ok-Kyung Kim1,2, Da-Eun Nam1, Young S Hahn1,3.   

Abstract

BACKGROUND AND AIMS: HCV infection is a major risk factor that can lead to chronic liver disease, including fibrosis, cirrhosis, and HCC. Progression of chronic liver disease by HCV infection is caused by a complex intercellular reaction. Especially, exosomes and microRNAs (miRNAs) from HCV-infected hepatocytes play a role in the pathogenesis of liver disease by facilitating cellular communication between parenchymal and nonparenchymal cells. However, the underlying mechanism of secretions of exosome and miRNAs during HCV infection is still open for study. APPROACH AND
RESULTS: In this study, we demonstrated a pathway for the release of exosome and exosomal miRNAs through caspase-3/pannexin 1 (Panx1)/P2X4 activation during HCV infection in hepatocytes. We found that HCV infection induced the stimulation of exosome release and activation of the caspase-3/Panx1/P2X4 pathway in Huh7.5.1 cells. In addition, miR-122 and miR-146a levels in extracellular exosomes from HCV-infected cells were dramatically increased whereas intracellular miR122 and miR-146a expression had no large changes. Notably, secretions of exosomes and exosomal miRNAs were decreased by inhibition of caspase 3, Panx1, and P2X4 whereas inhibition of ROCK-1 cleavage did not affect these during HCV infection in Huh7.5.1 cells.
CONCLUSIONS: These results suggested that HCV infection caused secretions of exosomes and exosomal miRNAs dependent on the caspase 3/Panx1/P2X4 pathway. Our study provides a possible therapeutic intervention using Panx1 suppression for liver disease development mediated by exosomes from HCV-infected hepatocytes.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34218459      PMCID: PMC8639610          DOI: 10.1002/hep.32042

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  48 in total

1.  Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes.

Authors:  Libin Deng; Wang Jiang; Xiaoning Wang; Andreas Merz; Marie-Sophie Hiet; Yujie Chen; Xiaoyu Pan; Yaming Jiu; Yu Yang; Bowen Yu; Yongning He; Zhengkun Tu; Junqi Niu; Ralf Bartenschlager; Gang Long
Journal:  J Hepatol       Date:  2019-03-15       Impact factor: 25.083

Review 2.  Microvesicles and exosomes for intracardiac communication.

Authors:  Joost P G Sluijter; Vera Verhage; Janine C Deddens; Frederieke van den Akker; Pieter A Doevendans
Journal:  Cardiovasc Res       Date:  2014-01-30       Impact factor: 10.787

3.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Authors:  Timea Csak; Michal Ganz; Justin Pespisa; Karen Kodys; Angela Dolganiuc; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia.

Authors:  Mara H de Pina-Benabou; Vanessa Szostak; Andreas Kyrozis; David Rempe; Daniela Uziel; Marcia Urban-Maldonado; Salomon Benabou; David C Spray; Howard J Federoff; Patric K Stanton; Renato Rozental
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

5.  P2X7 receptor-Pannexin1 interaction mediates stress-induced interleukin-1 beta expression in human periodontal ligament cells.

Authors:  K Kanjanamekanant; P Luckprom; P Pavasant
Journal:  J Periodontal Res       Date:  2013-11-13       Impact factor: 4.419

6.  Rab27a and Rab27b control different steps of the exosome secretion pathway.

Authors:  Matias Ostrowski; Nuno B Carmo; Sophie Krumeich; Isabelle Fanget; Graça Raposo; Ariel Savina; Catarina F Moita; Kristine Schauer; Alistair N Hume; Rui P Freitas; Bruno Goud; Philippe Benaroch; Nir Hacohen; Mitsunori Fukuda; Claire Desnos; Miguel C Seabra; François Darchen; Sebastian Amigorena; Luis F Moita; Clotilde Thery
Journal:  Nat Cell Biol       Date:  2009-12-06       Impact factor: 28.824

7.  Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles.

Authors:  A N Böing; J Stap; C M Hau; G B Afink; C Ris-Stalpers; E A Reits; A Sturk; C J F van Noorden; R Nieuwland
Journal:  Biochim Biophys Acta       Date:  2013-03-24

8.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs.

Authors:  Carolina Villarroya-Beltri; Cristina Gutiérrez-Vázquez; Fátima Sánchez-Cabo; Daniel Pérez-Hernández; Jesús Vázquez; Noa Martin-Cofreces; Dannys Jorge Martinez-Herrera; Alberto Pascual-Montano; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications.

Authors:  Chiara Corrado; Stefania Raimondo; Antonio Chiesi; Francesco Ciccia; Giacomo De Leo; Riccardo Alessandro
Journal:  Int J Mol Sci       Date:  2013-03-06       Impact factor: 5.923

10.  Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect.

Authors:  Tzu-Chun Chen; Chung-Han Hsieh; Peter Sarnow
Journal:  PLoS Pathog       Date:  2015-08-25       Impact factor: 6.823

View more
  2 in total

1.  Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels.

Authors:  Anne Caufriez; Andrés Tabernilla; Raf Van Campenhout; Axelle Cooreman; Kaat Leroy; Julen Sanz Serrano; Prashant Kadam; Bruna Dos Santos Rodrigues; Arthur Lamouroux; Steven Ballet; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

2.  Hepatic pannexin-1 mediates ST2+ regulatory T cells promoting resolution of inflammation in lipopolysaccharide-induced endotoxemia.

Authors:  Pusen Wang; Baojie Shi; Chunguang Wang; Yuanyuan Wang; Weitao Que; Zhongyi Jiang; Xueni Liu; Qianwei Jiang; Hao Li; Zhihai Peng; Lin Zhong
Journal:  Clin Transl Med       Date:  2022-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.